Assyro AI

Orange Book product · Generic (ANDA)

BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE

BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE

Generic (ANDA)ANDA 212212TE ABRX TEVA PHARMS USA INC

At a glance

Apr 23, 2026

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 23, 2026

    2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE

Strength

0.08MG/INH;0.0045MG/INH

Dosage form

AEROSOL, METERED

Route

INHALATION

TE code

AB

Application

ANDA 212212

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.